Category: Globe Newswire

Posted Date:

November 12, 2026

AirJoule Technologies Schedules Release of Third Quarter 2026 Results and Conference Call

AirJoule Technologies Corporation

November 12, 2026
BANK OF AMERICA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bank of America and Encourages Investors to Contact the Firm

Bragar Eagel & Squire

November 12, 2026
D-WAVE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds D-Wave Quantum Inc. Investors with Large Losses to Contact the Firm Before December 14th Seeking Lead Plaintiff Role

Bragar Eagel & Squire

November 12, 2026
Standard Lithium Reports Third Quarter 2026 Results

Standard Lithium

November 12, 2026
Prairie Operating Co. Announces Third Quarter 2026 Results

Prairie Operating Co.

November 12, 2026
Future Technologies Expands Licensed Microwave Support to Help Cambium Legacy Customers Protect Network Investments

Future Technologies Venture, LLC

November 12, 2026
Robinhood Markets, Inc. Reports October 2026 Operating Data

Robinhood Markets, Inc.

November 12, 2026
Gemini Reports Third Quarter 2026 Results

Gemini Space Station, Inc.

November 12, 2026
authID Reports Financial and Operating Results for the Third Quarter 2026

authID Inc.

November 12, 2026
Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights

Sutro Biopharma, Inc.

November 12, 2026
Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day

Praxis Precision Medicines, Inc.

November 12, 2026
Aeluma Announces First Quarter Fiscal 2027 Financial Results

Aeluma, Inc.

November 12, 2026
Martinrea International Inc. Reports Third Quarter Results and Declares Dividend

Martinrea International Inc.

November 12, 2026
CC INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges The Chemours Company Investors to Contact the Firm Before December 7th Seeking Lead Plaintiff Role

Bragar Eagel & Squire

November 12, 2026
ILLR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Triller Group Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire

November 12, 2026
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

Cullinan Therapeutics, Inc.

November 12, 2026
Lulus Reports Third Quarter 2026 Results

Lulu’s Fashion Lounge Holdings, Inc.

November 12, 2026
Correction to the Annual General Meeting Venue Address

CTW

November 12, 2026
dLocal Reports Third Quarter 2026 Financial Results

DLocal Limited

November 12, 2026
Navitas Files Patent Infringement Lawsuit Against Newly Announced Renesas GaN Products

Navitas Semiconductor Corporation

November 12, 2026
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results

Verrica Pharmaceuticals Inc.

November 12, 2026
MILLROSE PROPERTIES ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Millrose Properties, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire

November 12, 2026
Sanara MedTech Inc. Reports Third Quarter 2026 Financial Results (Unaudited)

Sanara MedTech Inc.

November 12, 2026
Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Relmada Therapeutics

November 12, 2026
NeoVolta Reports Financial Results for Quarter Ended September 30, 2026

NeoVolta Inc.

November 12, 2026
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Crescent Biopharma, Inc.

November 12, 2026
Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Bolt Biotherapeutics, Inc.

November 12, 2026
4DMT Reports Third Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones

4D Molecular Therapeutics, Inc.

November 12, 2026
ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieves Quarterly Profitability

ROC

November 12, 2026
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update

Azora Therapeutics, Inc

November 12, 2026
FinWise Bancorp Announces Increase in Share Repurchase Program

FinWise Bank

November 12, 2026
PEDEVCO Reports Third Quarter 2026 Results

PEDEVCO Corp.

November 12, 2026
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates

ADARx Pharmaceuticals Inc.

November 12, 2026
Equillium Reports Third Quarter 2026 Financial Results and Recent Corporate and Clinical Highlights

Equillium, Inc.

November 12, 2026
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand Use of Portfolio

BioStem Technologies, Inc.

November 12, 2026
Pyxis Tankers Agrees to Sell Pyxis Karteria at an Expected $21.0 Million Gain $37.0 million sale price expected to generate a gain of approximately $2.05 per share and support fleet expansion and renewal

Pyxis Tankers Inc.

November 12, 2026
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026

ImmuCell Corporation

November 12, 2026
Innventure Reports Third Quarter 2026 Results

Innventure, Inc.

November 12, 2026
Fluent Announces Third Quarter 2026 Financial Results; Commerce Media Solutions Revenue Doubles and Annual Run Rate Now Exceeds $145 Million

Fluent, Inc.

November 12, 2026
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Scribe Therapeutics Inc.

November 12, 2026
Royalty Pharma to present at the UBS Global Biopharma Conference

Royalty Pharma plc

November 12, 2026
ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing

ProMIS Neurosciences Inc.

November 12, 2026
SoundThinking, Inc. Reports Third Quarter 2026 Financial Results

SoundThinking, Inc.

November 12, 2026
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Prime Medicine, Inc.

November 12, 2026
Shimmick Corporation Announces Third Quarter 2026 Results

Shimmick Corporation

November 12, 2026
Energous Wireless Power Solutions Reports Third Quarter 2026 Results

Energous

November 12, 2026
Voting Rights and Shares Capital of the Company

Nanobiotix S.A.

November 12, 2026
Birchtech Reports Third Quarter 2026 Financial Results

Birchtech Corp.

November 12, 2026
Adams Diversified Equity Fund Declares Distribution

Adams Diversified Equity Fund, Inc.

November 12, 2026
Wealthfront to Announce Fiscal Third Quarter 2027 Financial Results on December 3, 2026

Wealthfront Corporation

November 12, 2026
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Candel Therapeutics

November 12, 2026
Rekor Systems Reports Third Quarter 2026 Financial Results

Rekor Systems

November 12, 2026
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Immix Biopharma, Inc.

November 12, 2026
Cerebras Systems Delivers Record Revenue in Third Quarter 2026, Raises Full-Year Outlook

Cerebras Systems Inc.

November 12, 2026
InspireMD Announces Proposed Public Offering

InspireMD Inc.

November 12, 2026
Snail, Inc. Reports Third Quarter 2026 Financial Results

Snail, Inc.

November 12, 2026
Adams Natural Resources Fund Declares Distribution

Adams Natural Resources Fund, Inc.

November 12, 2026
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock

Digital Realty

November 12, 2026
VirTra Reports Third Quarter and Nine Months 2026 Financial Results

VirTra, Inc.

November 12, 2026
ProKidney Reports Third Quarter 2026 Financial Results and Business Highlights

ProKidney

November 12, 2026
Xos Extends Gross Profit Streak, Highlighting Operational Efficiency

Xos, Inc.

November 12, 2026
SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update

SELLAS Life Sciences Group, Inc.

November 12, 2026
Inuvo Third Quarter 2026 Results Reflect Inflection Point as IntentKey Pipeline Builds

Inuvo Inc.

November 12, 2026
SKYX Reports Record Revenue of $25.7M in Q-3 2026 Compared to $23.9M in Q-3 2025 and 11 Consecutive Quarters of Growth YoY

SKYX Platforms Corp.

November 12, 2026
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Shattuck Labs, Inc.

November 12, 2026
AmpliTech Group Reports Q3 2026 Revenue of $6.58 Million, Up 8.0% Year-over-Year, and 41.1% Nine-Month Gross Profit Growth

AmpliTech Group, Inc.

November 12, 2026
MediaAlpha Announces $16 Million Private Stock Repurchase

MediaAlpha, Inc.

November 12, 2026
Oportun to Present at Stephens NASH2026 Annual Investor Conference

Oportun Financial Corporation

November 12, 2026
OpenWorld, Inc. Reports 2026 Third Quarter Results; First Quarterly Results as a Nasdaq-Listed Company

OpenWorld, Inc.

November 12, 2026
Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates

Alumis Inc.

November 12, 2026
Anavex Life Sciences Corp. Investors Seeking Lead Plaintiff Role Have Until November 30th to Contact Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire

November 12, 2026
Merlin, Inc. Reports Third Quarter 2026 Results

Merlin Labs, Inc.

November 12, 2026
Liftoff Mobile Announces Third Quarter 2026 Financial Results

Liftoff Mobile

November 12, 2026
PRF Technologies Receives Nasdaq Delisting Determination Regarding Minimum Bid Price Requirement and Requests a Hearing

PRF Technologies Ltd.

November 12, 2026
LOBO TECHNOLOGIES LTD. Announces Share Consolidation

LOBO EV TECHNOLOGIES LTD.

November 12, 2026
Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

Heartflow, Inc.

November 12, 2026
Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights

Electra Therapeutics, Inc.

November 12, 2026
InspireMD Reports Third Quarter 2026 Financial Results

InspireMD Inc.

November 12, 2026
Workhorse Group Postpones Third Quarter Earnings Release and Conference Call

Workhorse Group, Inc.

November 12, 2026
Biomea Fusion to Participate in Upcoming Investor Conferences

Biomea Fusion, Inc.

November 12, 2026
Wise Group plc H1 Results for Fiscal Year 2027

Wise Limited

November 12, 2026
Winter is roof season as Colorado renewals start showing wildfire scores

CEDUR

November 12, 2026
TMC Provides Third Quarter 2026 Corporate Update

The Metals Company

November 12, 2026
Globus Maritime Sets Date for the Release of Third Quarter and Nine Months 2026 Results

Globus Maritime Limited

November 12, 2026
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Black Diamond Therapeutics, Inc

November 12, 2026
Spero Therapeutics Announces Third Quarter 2026 Operating Results and Provides Business Update

Spero Therapeutics, Inc.

November 12, 2026
U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027

U.S. Global Investors

November 12, 2026
NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update

NuCana plc

November 12, 2026
WidePoint Reports Third Quarter 2026 Financial Results

WidePoint Corporation

November 12, 2026
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Pliant Therapeutics, Inc.

November 12, 2026
Mdxhealth Reports Third Quarter 2026 Financial Results

mdxhealth

November 12, 2026
Erasca Reports Third Quarter 2026 Business Updates and Financial Results

Erasca, Inc.

November 12, 2026
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Journey Medical Corporation

November 12, 2026
Accelevation Holdings Corp. Reports Strong Third Quarter 2026 with Revenue Growth of 66%, Bookings Growth of over 350%, and Robust Cash Generation

Accelevation

November 12, 2026
Analysis from Fight Colorectal Cancer Reveals Significant Gap in Biomarker Testing For Patients with Colorectal Cancer

Fight Colorectal Cancer

November 12, 2026
Park Dental Partners Announces Third Quarter 2026 Results

Park Dental Partners

November 12, 2026
InspireMD Announces FDA Approval of the CGuard® Prime TransCarotid Stent System for Transcarotid Artery Revascularization (TCAR) Procedures

InspireMD Inc.

November 12, 2026
Bragar Eagel & Squire, P.C. Urges The Ensign Group, Inc. Investors to Contact the Firm Before December 7th Seeking Lead Plaintiff Role

Bragar Eagel & Squire

November 12, 2026
Beeline Q3 2026 Revenue Increases 30% Year-Over-Year; Net Loss Decreases 6% and Adjusted EBITDA Loss Narrows 33% Sequentially

Beeline Holdings Inc.

November 12, 2026
Jefferson Capital Reports Third Quarter 2026 Results

Jefferson Capital

November 12, 2026